Trials / Completed
CompletedNCT02072447
Absolute Bioavailability of YH4808 With Accelerator Mass Spectrometry(AMS)-Based Microdose Study
A Study to Determine the Absolute Bioavailability of YH4808 Using Simultaneous Oral Therapeutic- and [14C]-Labeled Intravenous Microdoses
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study aims to determine the absolute bioavailability of YH4808 using simultaneous oral therapeutic- and \[14C\]-labeled intravenous microdoses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YH4808 PO and [14C]-YH4808 IV |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2014-02-26
- Last updated
- 2014-04-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02072447. Inclusion in this directory is not an endorsement.